Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases

Sakari Kauppinen

Press/Media: Press / Media

Description

Sakari Kauppinen, Professor from the Center for RNA Medicine, Aalborg University, is one of the scientific founders of Resalis, which has just finished a seed financing round of EUR 10 millions to establish a non-coding RNA-based therapeutic approach for the treatment of metabolic diseases. With the funding, Resalis will finalise the development of RES-010 as a novel treatment for obesity and nonalcoholic fatty liver disease. (Summary provided by Infomedia) Sources: Street Insider, 22-02-2023 Barchart, 22-02-2023 Yahoo! Finance, 22-02-2023 Fat Pitch Financials, 22-02-2023 MyMotherLode, 22-02-2023 Maria Liberati, 22-02-2023 Benzinga, 22-02-2023 Biotech 365, 22-02-2023 Ca.advfn, 22-02-2023 Advfn, 22-02-2023 Business.decaturdailydemocrat.com, 22-02-2023 BioSpace, 22-02-2023 The Evening Leader, 22-02-2023 AP News, 22-02-2023 The Antlers American, 22-02-2023 Livermore, 22-02-2023 The AI Journal, 22-02-2023 Business.malvern-online.com, 22-02-2023 The Post and Mail, 22-02-2023 Sweet Water Reporter, 22-02-2023 Finanzas Yahoo, 22-02-2023 The Pilot News, 22-02-2023 Mammoth Times, 22-02-2023 FirstWord Pharma, 22-02-2023 Market Minute, 22-02-2023 Acrofan, 22-02-2023 PipelineReview, 22-02-2023 Morningstar.com, 22-02-2023 Benton Courier, 22-02-2023 St. Marys Daily Press, 22-02-2023 Financial Content, 22-02-2023 Business.punxsutawneyspirit, 22-02-2023 Spoke.com, 22-02-2023 Business Wire, 22-02-2023 Pharmaceutical daily, 22-02-2023 Azcentral, 22-02-2023 Stock Market Summary, 22-02-2023 Finanz Nachrichten, 22-02-2023 Minyanville, 22-02-2023 Markets.post-gazette.com, 22-02-2023

Period	22 Feb 2023

Media coverage

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	PipelineReview
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Pharmaceutical daily
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	FirstWord Pharma
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Finanzas Yahoo
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Biotech 365
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	BioSpace
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases Follow Spoke
Media name/outlet	Spoke.com
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Business.punxsutawneyspirit
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	AP News
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Yahoo! Finance
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Azcentral
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Finanz Nachrichten
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	The Post and Mail
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Mammoth Times
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Maria Liberati
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	The AI Journal
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Morningstar.com
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Benzinga
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Livermore
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Market Minute
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Financial Content
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	The Evening Leader
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Business Wire
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Acrofan
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Business.malvern-online.com
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Ca.advfn
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Barchart
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Sweet Water Reporter
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	MyMotherLode
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Advfn
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Business.decaturdailydemocrat.com
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Fat Pitch Financials
Date	22/02/2023
Producer/Author	By: Resalis Therapeutics via Business Wire
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Street Insider
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	The Pilot News
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Minyanville
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Markets.post-gazette.com
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	The Antlers American
Date	22/02/2023
Producer/Author	By: Resalis Therapeutics via Business Wire
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Stock Market Summary
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	St. Marys Daily Press
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

Title	Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
Media name/outlet	Benton Courier
Date	22/02/2023
URL	Login to display link to press clippings from Infomedia
Persons	Sakari Kauppinen

View all 40

View less